EntreMed (ENMD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sol W. who wrote (1666)	2/12/1999 8:12:00 AM
From: Vincent Vega	Read Replies (2) of 2135

From the WSJ.... <<Whether the two agents can eradicate tumors not just in mice but in humans is still open to question. And some scientists say that confirmation in someone else's lab doesn't amount to verification. "Independent confirmation of Folkman would be very exciting; however, these results don't qualify as such," said George Yancopoulos, chief scientific officer at Regeneron Pharmaceuticals Inc., an expert in the blood-vessel field. "What worries me is that several years after the discovery of endostatin, there is still no explanation for how it works. It's still black magic," Dr. Yancopoulos added. >> Anyone out there anxious to be the first human they try this on?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next